Unclaimed brand
Evercyte - the pharmacocellomicsTM company. Vision Acceleration of drug finding and development by reduction of development time and cost by introducing panels of immortalized human cell strains for drug screening strategies. Evercyte will establish the new concept of “pharmacocellomicsTM” in the field of pre-clinical developments. Therefore, we will provide primary cells from different patients and tissues that are immortalized by telomerase or other strategies (SV40; SNEV) that we have established. Thus we guarantee cell strains with the most similar phenotype to the primary cells in sufficient amounts to perform reproducible preclinical drug testing. We will deliver (i) single immortalized cell strains including mesenchymal stem cells that can be differentiated to the cell type of interest; (ii) cell panels including sufficient cell strains of different tissues and/or donors of different status (healthy, diseased, young, old, etc) in order to generate statistically meaningful data that allow to estimate drug efficiencies and toxicity with high predictive power. Finally, (iii) we will establish customer-tailored immortalized cell strains according to the needs of specific customers.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#8BC34A
Sushi
139, 195, 74
88, 50, 53
29, 0, 62, 24
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#00639A
Bahama Blue
0, 99, 154
201, 100, 30
100, 36, 0, 40
Evercyte is a biotechnology company focused on providing human cell models and related services for biomedical and biotechnological research. It develops specialized, human primary-like cells with extended proliferative capacity, using hTERT expression to help address the limited lifespan of conventional primary cells while retaining cell-type-specific characteristics. These cells support standardized in vitro and preclinical test systems, including applications such as toxicity, drug and potency testing, and advanced platforms such as organ-on-a-chip systems.
Evercyte’s product range includes human cells catalogued by cell type or tissue and body fluid, cell culture media, and extracellular vesicles (EVs), including off-the-shelf EVs from mesenchymal stromal cells. The company also offers corresponding cell factories for EV production, with applications described for research and clinical use. Its services include custom cell-line development, cell reprogramming, gene editing, drug screening, EV enrichment and characterization, potency testing, and provision of assay-ready cells. Evercyte also provides information and resources about its cells and media.
Company type
Privately Held
Year founded
2011
Company size
2-10 employees
The Evercyte GmbH name, logos and brand assets are trademarks of Evercyte GmbH and its affiliates. Brandfetch isn't affiliated with or endorsed by Evercyte GmbH. Their use is subject to Evercyte GmbH's brand guidelines.
